Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 protein

FEBS Letters

Volumn 580, Issue 6, 2006, Pages 1659-1664

  Alimirah, Fatouma ^a   Chen, Jianming ^a   Xin, Hong ^a   Choubey, Divaker ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Androgen receptor; IFI16; Interferon; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; PROTEIN IFI16; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 33344475446     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.02.015     Document Type: Article

References (29)

1. C. Abate-Shen, and M.M. Shen Molecular genetics of prostate cancer Genes Dev. 14 2000 2410 2434
2. C. Abate-Shen, and M.M. Shen Mouse models of prostate carcinogenesis Trends Genet. 18 2002 S1 S5
3. C.A. Heinlein, and C. Chang Androgen receptor in prostate cancer Endocr. Rev. 25 2004 276 308
4. K.C. Day, M.T. McCabe, X. Zhao, Y. Wang, J.N. Davis, J. Phillips, M. Von Geldern, T. Ried, M.A. KuKuruga, G.R. Cunha, S.W. Hayward, and M.L. Day Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis J. Biol. Chem. 277 2002 44478 44484
5. S.M. Phillips, C.M. Barton, S.J. Lee, D.G. Morton, D.M. Wallace, N.R. Lemoine, and J.P. Neoptolemos Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostate tumorigenesis Br. J. Cancer 70 1994 1252 1257
6. W.D. Tilley, G. Buchanan, T.E. Hickey, and J.M. Bentel Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence Clin. Cancer Res. 2 1996 277 285
7. A.J. Asirvatham, M. Schmidt, B. Gao, and J. Chaudhary Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells Endocrinology 147 2005 257 271
8. Basrawala, Z., Alimirah, F., Xin, H., Mohideen, N., Campbell, S.C., Flanigan, R.C. and Choubey, D. (2005). Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells. Oncogene (Epub ahead of print).
9. D.J. Bettoun, A. Scafonas, S.J. Rutledge, P. Hodor, O. Chen, C. Gambone, R. Vogel, S. McElwee-Witmer, C. Bai, L.P. Freedman, and A. Schmidt Interaction between the androgen receptor and RNaseL mediates a crosstalk between the interferon and androgen signaling pathways J. Biol. Chem. 280 2005 38898 38901
10. R.W. Johnstone, and J.A. Trapani Transcription and growth regulatory functions of the HIN-200 family of proteins Mol. Cell. Biol. 19 1999 5833 5838
11. D. Choubey p202: An interferon-inducible negative regulator of cell growth J. Biol. Regul. Homeost. Agents 14 2000 187 192
12. D. Choubey, and B.L. Kotzin Interferon-inducible p202 in the susceptibility to systemic lupus Front. Biosci. 7 2002 e252 e262
13. H. Xin, J. Curry, R.W. Johnstone, B.J. Nickoloff, and D. Choubey Role of IFI16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence Oncogene 22 2003 4831 4840
14. H. Xin, O.M. Pereira-Smith, and D. Choubey Role of IFI16 in cellular senescence of human fibroblasts Oncogene 23 2004 6209 6217
15. J.A. Aglipay, S.W. Lee, S. Okada, N. Fujiuchi, T. Ohtsuka, J.C. Kwak, Y. Wang, R.W. Johnstone, C. Deng, J. Qin, and T.A. Ouchi A member of the pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway Oncogene 22 2003 8931 8938
16. R.W. Johnstone, W. Wei, A. Greenway, and J.A. Trapani Functional interaction between p53 and the interferon-inducible nucleoprotein IFI16 Oncogene 19 2000 6033 6042
17. X. Wang, H. Deng, I. Basu, and L. Zhu Induction of androgen receptor-dependent apoptosis in prostate cancer cells by the retinoblastoma protein Cancer Res. 64 2004 1377 1385
18. D. Choubey, S.J. Li, B. Datta, J.U. Gutterman, and P. Lengyel Inhibition of E2F-mediated transcription by p202 EMBO J. 15 1996 5668 5678
19. A. Chlenski, K. Nakashiro, K.V. Ketels, G.I. Korovaitseva, and R. Oyasu Androgen receptor expression in androgen-independent prostate cancer cell lines Prostate 47 2001 66 75
20. P.W. Hinds, and R.A. Weinberg Tumor suppressor genes Curr. Opin. Genet. Dev. 4 1994 135 141
21. D.F. Jarrard, S. Sarkar, Y. Shi, T.R. Yeager, G. Magrane, H. Kinoshita, N. Nassif, L. Meisner, M.A. Newton, F.M. Waldman, and C.A. Reznikoff p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells Cancer Res. 59 1999 2957 2964
22. L.A. Garraway, D. Lin, S. Signoretti, D. Waltregny, J. Dilks, N. Bhattacharya, and M. Loda Intermediate basal cells of the prostate: in vitro and in vivo characterization Prostate 55 2003 206 218
23. S. Yuan, J. Trachtenberg, G.B. Mills, T.J. Brown, F. Xu, and A. Keating Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA Cancer Res. 53 1993 1304 1311
24. L.E. Heisler, A. Evangelou, A.M. Lew, J. Trachtenberg, H.P. Elsholtz, and T.J. Brown Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor Mol. Cell Endocrinol. 126 1997 59 73
25. M. Burchardt, T. Burchardt, A. Shabsigh, M. Ghafar, M.W. Chen, A. Anastasiadis, A. de la Taille, A. Kiss, and R. Buttyan Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells Prostate 48 2001 225 230
26. S. Knight-Krajewski, C.F. Welsh, Y. Liu, L.S. Lyons, J.M. Faysal, E.S. Yang, and K.L. Burnstein Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells Oncogene 23 2004 5513 5522
27. A. Bubulya, S.C. Wise, X.Q. Shen, L.A. Burmeister, and L. Shemshedini c-Jun can mediate androgen receptor-induced transactivation J. Biol. Chem. 271 1996 24583 24589
28. C.J. Clarke, V. Apostolidis, L.L. Hii, D.J. Gough, J.A. Trapani, and R.W. Johnstone Critical role of the transcription factor AP-1 for the constitutive and interferon-induced expression of IFI16 J. Cell. Biochem. 89 2003 80 93
29. B. He, J.A. Kemppainen, and E.M. Wilson FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand-binding domain of the androgen receptor J. Biol. Chem. 275 2000 22986 22994